HB 1741 Introduced

Expanding access to treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

Last action: 2026-01-12 — By resolution, reintroduced and retained in present status.

Take Action

Official Description

No official description available.

Bill Details

Bill Number
HB 1741
Current Status
Introduced
Chamber
House

How to Make Your Voice Heard

1. Submit Written Comment

Click "Comment on This Bill" above. You have up to 5,000 characters. Comments are typically open for 24 hours before hearings.

2. Testify at Hearing

Sign up to testify remotely via TVW. Check the legislative calendar for hearing times.

3. Contact Your Legislator

Use the district finder to find your representatives and reach out directly.